TNFSF14 and neoplasm: Our findings indicate that recombinant mouse LIGHT (not human LIGHT) in a preclinical mouse model can promote beneficial responses through the recruitment of critical immune effector cells (cytotoxic cells and dendritic cells) in the tumor parenchyma.